RxElite, Inc. http://www.rxelite.com/ last week said it received financing from NPIL Pharma Inc.
Meridian-based RxElite develops, manufactures and markets specialty generic prescription drugs. The company said in a release that it entered an agreement with NPIL Pharma to fund up to $5 million through a secured, subordinated debt agreement. NPIL advanced $3 million of the total to RxElite at the conclusion of the transaction.
Full Story: http://www.idahobusiness.net/archive.htm/2008/06/11/RxElite-receives-frunding-from-NPIL-Pharma